Skip to content

EFFICACY OF VIJAYANANDA RASA IN SHWITRA (Vitiligo)

PHARMACEUTICAL STANDARDIZATION OF VIJAYANANDA RASA AND ITS EFFICACY IN MANAGEMENT OF SHWITRA (Vitiligo) - NIL

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/01/007728
Enrollment
10
Registered
2017-01-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient having sign and symptoms of Shwitra(Vitiligo),Curable symptoms(sadhya laxana) of disease, age 16-60 years, Woods lamp test positive are to be selected.

Interventions

Intervention1: Vijayananda rasa: Route Of administration-Oral Dose-60mg B.D. Duration-4 weeks Anupana(After dose)-Luke warm water Indication-Shwitra(Vitiligo)

Sponsors

JSAyurveda College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient having sign and symptom of Shwitra, Sadhya lakshana of Shwitra, Age 16-60 years, Chronicity of less than 10 years, Woodâ??s lamp test positive. Classical symptoms: Twak varna: Change in skin colour of hypopigmented patches from adjacent skin â?? Rakta, Tamra, Sweta, Pandura and Ruksha. Either segmental or Non segmental vitiligo could be included in inclusion criteria. Sadhya lakshana- Arakta Loma(Not covered with red hair), Ashukla(Non whitish), Tanu or Abahal(Thin), Pandu(Pallor), Naati chirotthita (Not of long duration), Navin (New), Unnam(Elevated), Madhyaavakasham (Elevated in center),Asansrista, Anagnidagdhajam(Except Burn).

Exclusion criteria

Exclusion criteria: 1.Age below 16 and above 60 years 2.Patient with associated diseases like cancer,Diabetics with uncontrollable blood sugars,HIV and secondary skin infections involving large body part. 3.Pregnant woman 4.Lactating mother 5.Patient of any other severe illness 6.Patients on drugs which are responsible for photosensitivity or cause hyperpigmentation of skin , patients on modern treatment of vitiligo like cytotoxic or disease modifying drugs like methotrexate, systemic corticosteroids since long time, receiving local drugs for Hyperpigmentation, receiving any other drugs for the management of Shwitra(Vitiligo).

Design outcomes

Primary

MeasureTime frame
The patients are selected from P.D.Patel Ayurved Hospital.Minimum 10 patients are selected for this research work.The obtained data will be statastically analyzed with the help of student "t" test.Timepoint: Duration - 4 weeks Follow up -15 days

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDrUpendraUZala

J.S.AYURVEDA COLLEGE , NADIAD

drdhaval16@gmail.com9427182516

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026